CSI Market
Sign In | Register

Axim Biotechnologies Inc (AXIM) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access AXIM Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Axim Biotechnologies Inc balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2024)
(Mar 31 2024) (Dec 31 2023) (Sep 30 2023) (Jun 30 2023)
Assets
Cash & cash equivalent0.00
Security Deposit0.01
Cash & Short-term Investments0.00
Other Current Assets0.00
Prepaid Supplies PR0.01
Total Current Assets0.02
Equipment/Property/Plant Net0.12
Intangible Assets3.40
Other Assets, Noncurrent0.19
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents0.01
Operating Lease Right Of Use Asset0.18
Total Assets3.73
Liabilities
Accounts Payable and Accrued Liabilities, Current LI1.67
Derivative Liability, Current DE4.12
Long-term Debt and Capital Lease Obligations, Current DE0.09
Other Liabilities, Current0.00
Deferred Revenue, Current DE0.23
Total Current Liabilities6.57
Long-term debt0.09
Capital Lease Obligations, Noncurrent LO0.00
Convertible Debt, Noncurrent LO5.04
Total Long-term Debt5.13
Other liabilities, Noncurrent0.00
Due To Related Party Current0.01
Advances From Shareholders Current0.45
Lease Liability Obligations-
Advances From Shareholder-
Convertible Note Payable Including Accrued Interest Net Of Unamortized Debt Discount-
Total Liabilities13.26
Stockholders' Equity
Common Stock To Be Issued-
Common Stock Value0.03
Common Stock, Held by Subsidiary etc.-
Additional Paid In Capital Common Stock65.18
Retained Earnings / Accumulated Deficit-74.75
Other Equity0.00
Common Stockholder's Equity-9.53
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-9.53
Liabilities & Stockholder's Equity3.73
4 historic quarters locked

Sign in to unlock the full Axim Biotechnologies Inc balance sheet history.

Sign In Create Free Account

About Axim Biotechnologies Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20240630)
  • Filed with the SEC: August 19, 2024
  • Source: axim_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001096906-24-001772

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.